Chemistry Wealth Management’s New York Times NYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Hold
4,363
0.05% 170
2026
Q1
$365K Hold
4,363
0.06% 151
2025
Q4
$303K Hold
4,363
0.06% 158
2025
Q3
$250K Hold
4,363
0.05% 179
2025
Q2
$244K Hold
4,363
0.05% 171
2025
Q1
$216K Hold
4,363
0.05% 174
2024
Q4
$227K Hold
4,363
0.05% 162
2024
Q3
$243K Hold
4,363
0.06% 153
2024
Q2
$223K Buy
+4,363
New +$205K 0.06% 151
2024
Q1
Sell
-4,567
Closed -$224K 167
2023
Q4
$224K Buy
+4,567
New +$201K 0.07% 139
2022
Q2
Sell
-4,567
Closed -$209K 141
2022
Q1
$209K Buy
+4,567
New +$198K 0.07% 133

Other funds holding NYT

Chemistry Wealth Management's NYT Position: Q2 2026 in Review

Chemistry Wealth Management held its New York Times (NYT) position steady in Q2 2026 at 4,363 shares worth $305K. The position accounts for 0.05% of the portfolio, ranked #170.

Chemistry Wealth Management first reported a position in NYT in Q1 2022 and has held it in 11 quarters since. The position peaked at $365K in Q1 2026. 224 funds tracked by Wall St. Rank hold NYT as of Q2 2026.

  • Chemistry Wealth Management held 4,363 shares of New York Times worth $305K as of Q2 2026.
  • Chemistry Wealth Management left its New York Times share count unchanged in Q2 2026.
  • New York Times made up 0.05% of Chemistry Wealth Management's portfolio in Q2 2026, its #170 holding.
  • Chemistry Wealth Management first reported a position in New York Times in Q1 2022 and has held it in 11 quarters since.
  • Chemistry Wealth Management's New York Times position peaked at $365K in Q1 2026.
  • 224 funds tracked by Wall St. Rank held New York Times as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.